132 related articles for article (PubMed ID: 33246047)
1. Enhancement of atorvastatin oral bioavailability via encapsulation in polymeric nanoparticles.
Shaker MA; Elbadawy HM; Al Thagfan SS; Shaker MA
Int J Pharm; 2021 Jan; 592():120077. PubMed ID: 33246047
[TBL] [Abstract][Full Text] [Related]
2. Improved solubility, dissolution, and oral bioavailability for atorvastatin-Pluronic® solid dispersions.
Shaker MA; Elbadawy HM; Shaker MA
Int J Pharm; 2020 Jan; 574():118891. PubMed ID: 31786357
[TBL] [Abstract][Full Text] [Related]
3. Enhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticles.
Mady FM; Shaker MA
Int J Nanomedicine; 2017; 12():7405-7417. PubMed ID: 29066891
[TBL] [Abstract][Full Text] [Related]
4. Improved Stability and Enhanced Oral Bioavailability of Atorvastatin Loaded Stearic Acid Modified Gelatin Nanoparticles.
Shilpi D; Kushwah V; Agrawal AK; Jain S
Pharm Res; 2017 Jul; 34(7):1505-1516. PubMed ID: 28466393
[TBL] [Abstract][Full Text] [Related]
5. BCS class II drug loaded protein nanoparticles with enhanced oral bioavailability:
Kasekar NM; Singh S; Jadhav KR; Kadam VJ
Drug Dev Ind Pharm; 2020 Jun; 46(6):955-962. PubMed ID: 32362144
[TBL] [Abstract][Full Text] [Related]
6. The studies of PLGA nanoparticles loading atorvastatin calcium for oral administration
Li Z; Tao W; Zhang D; Wu C; Song B; Wang S; Wang T; Hu M; Liu X; Wang Y; Sun Y; Sun J
Asian J Pharm Sci; 2017 May; 12(3):285-291. PubMed ID: 32104340
[TBL] [Abstract][Full Text] [Related]
7. Design and Optimization of New Enteric Nanoparticles of Ceftriaxone for Oral Delivery: In vitro and in vivo Assessments.
Maghrabia A; Boughdady M; Meshali M
Int J Nanomedicine; 2021; 16():5937-5953. PubMed ID: 34511899
[TBL] [Abstract][Full Text] [Related]
8. Formulation of Gelucire®-Based Solid Dispersions of Atorvastatin Calcium: In Vitro Dissolution and In Vivo Bioavailability Study.
Aldosari BN; Almurshedi AS; Alfagih IM; AlQuadeib BT; Altamimi MA; Imam SS; Hussain A; Alqahtani F; Elzayat E; Alshehri S
AAPS PharmSciTech; 2021 May; 22(5):161. PubMed ID: 34031791
[TBL] [Abstract][Full Text] [Related]
9. Mucopenetrating nanoparticles for enhancement of oral bioavailability of furosemide: In vitro and in vivo evaluation/sub-acute toxicity study.
Radwan SE; Sokar MS; Abdelmonsif DA; El-Kamel AH
Int J Pharm; 2017 Jun; 526(1-2):366-379. PubMed ID: 28487189
[TBL] [Abstract][Full Text] [Related]
10. Enhanced oral bioavailability of acetylpuerarin by poly(lactide-co-glycolide) nanoparticles optimized using uniform design combined with response surface methodology.
Sun D; Xue A; Zhang B; Xue X; Zhang J; Liu W
Drug Des Devel Ther; 2016; 10():2029-39. PubMed ID: 27382256
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluation of 10-hydroxycamptothecin-loaded poly (n-butyl cyanoacrylate) nanoparticles prepared by miniemulsion polymerization.
Jin X; Asghar S; Zhu X; Chen Z; Tian C; Yin L; Ping Q; Xiao Y
Colloids Surf B Biointerfaces; 2018 Feb; 162():25-34. PubMed ID: 29145001
[TBL] [Abstract][Full Text] [Related]
12. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
13. Chitosan-TPP nanoparticles stabilized by poloxamer for controlling the release and enhancing the bioavailability of doxazosin mesylate:
Aljaeid BM; El-Say KM; Hosny KM
Drug Dev Ind Pharm; 2019 Jul; 45(7):1130-1139. PubMed ID: 30884977
[No Abstract] [Full Text] [Related]
14. Self-assembled phospholipid-based phytosomal nanocarriers as promising platforms for improving oral bioavailability of the anticancer celastrol.
Freag MS; Saleh WM; Abdallah OY
Int J Pharm; 2018 Jan; 535(1-2):18-26. PubMed ID: 29102699
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin-loaded pro-nanolipospheres with ameliorated oral bioavailability and antidyslipidemic activity.
Khafagy ES; Motawee AO; Ghorab MM; Gardouh AR
Colloids Surf B Biointerfaces; 2023 Jul; 227():113361. PubMed ID: 37236085
[TBL] [Abstract][Full Text] [Related]
16. Atazanavir-loaded Eudragit RL 100 nanoparticles to improve oral bioavailability: optimization and in vitro/in vivo appraisal.
Singh G; Pai RS
Drug Deliv; 2016; 23(2):532-9. PubMed ID: 24963752
[TBL] [Abstract][Full Text] [Related]
17. Oral delivery of indinavir using mPEG-PCL nanoparticles: preparation, optimization, cellular uptake, transport and pharmacokinetic evaluation.
Kurd M; Sadegh Malvajerd S; Rezaee S; Hamidi M; Derakhshandeh K
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2123-2133. PubMed ID: 31155961
[No Abstract] [Full Text] [Related]
18. Ethyl cellulose nanoparticles as a platform to decrease ulcerogenic potential of piroxicam: formulation and in vitro/in vivo evaluation.
El-Habashy SE; Allam AN; El-Kamel AH
Int J Nanomedicine; 2016; 11():2369-80. PubMed ID: 27307735
[TBL] [Abstract][Full Text] [Related]
19. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
Jin X; Huang A; Ping Q; Cao F; Su Z
Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
[TBL] [Abstract][Full Text] [Related]
20. Amphotericin B loaded ethyl cellulose nanoparticles with magnified oral bioavailability for safe and effective treatment of fungal infection.
Kaur K; Kumar P; Kush P
Biomed Pharmacother; 2020 Aug; 128():110297. PubMed ID: 32480227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
